Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Could Drug Price Spikes Spur ANDA Priority Reviews?

This article was originally published in The Pink Sheet Daily

Executive Summary

Sens. Collins and Warren want FDA to have economic trigger to speed generics; CDER's Woodcock says it's possible but needs clear legislative definition.

You may also be interested in...



Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

New FDA Commissioner tells employees that 'too many consumers are priced out of medicines they need' and that FDA must take meaningful steps to get lower cost alternatives to market.

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

New FDA Commissioner tells employees that 'too many consumers are priced out of medicines they need' and that FDA must take meaningful steps to get lower cost alternatives to market.

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Nothing seems conventional about this presidency, but history suggests a nomination may not arrive for another month or longer, and thereafter confirmation could be swift.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS079059

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel